Clinical impact of recently detected susceptibility genes for schizophrenia

Dialogues in Clinical Neuroscience

Volumn 8, Issue 1, 2006, Pages 79-84

  Maier, Wolfgang ^a   Zobel, Astrid ^a   Kühn, Kai Uwe ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Clinical implication; DTNBP1; G72 G30; Genetics; NRG1; Schizophrenia; Susceptibility gene

Indexed keywords

NEU DIFFERENTIATION FACTOR; PROTEIN KINASE B;

ARTICLE; BIPOLAR DISORDER; CHROMOSOME ANALYSIS; CLINICAL FEATURE; DNA MODIFICATION; DNA SEQUENCE; GENE EXPRESSION; GENE LOCUS; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; NONHUMAN; SCHIZOPHRENIA;

ANIMALS; CARRIER PROTEINS; CYTOGENETIC ANALYSIS; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); NERVE TISSUE PROTEINS; NEUREGULIN-1; PROTO-ONCOGENE PROTEINS C-AKT; SCHIZOPHRENIA;

EID: 33646135543     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Straub RE, Jiang Y, MacLean CJ, et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet. 2002;71:337-348.
2. Schwab SG, Knapp M, Mondabon S, et al. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet. 2003:72:185-190.
3. Stefansson H, Sigurdsson E, Steinthorsdottir V, et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet. 2002;71:877-892.
4. Chumakov I, Blumenfeld M, Guerassimenko O, et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA. 2002;99:13675-13680.
5. Tosato S, Dazzan P, Collier D. Association between the neuregulin 1 gene and schizophrenia: a systematic review. Schizophr Bull. 2005;31:613-617.
6. Blackwood DHR, Fordyce A, Walker MT, St Clair DM, Porteous DJ, Muir WJ. Schizophrenia and affective disorders - cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet. 2001;69:428-433.
7. Cannon TD, Hennah W, van Erp T, et al. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch Gen Psychiatry. 2005;62:1205-1213.
8. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet. 2004;36:131-137.
9. Schwab SG, Hoefgen B, Hanses C, et al. Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol Psychiatry. 2005;58:446-450.
10. Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin P. A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry. 2002;159:539-545.
11. Hattori E, Liu C, Badner JA, et al. Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. Am J Hum Genet. 2003;72:1131-1140.
12. Schumacher J, Jamra RA, Freudenberg J, et al. Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry. 2004;9:203-207.
13. Green EK, Raybould R, Macgregor S, et al. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Arch Gen Psychiatry. 2005;62:642-648.
14. Raybould R, Green EK, MacGregor S, et al. Bipolar disorder and polymorphisms in thedysbindin gene (DTNBP1). Biol Psychiatry. 2005:57:696-701.
15. Schulze TG, Ohlraun S, Czerski P, et al. Genotype-phenotype studies in bipolar disorder show associations between the DAOA/G30 locus and persecutory delusions: a first step towards a molecular genetic classification of psychiatric phenotypes. Am J Psychiatry. 2005;162:2101-2108.
16. Collier DA, Li T. The genetics of schizophrenia: glutamate not dopamine? Eur J Pharmacol. 2003;480:177-184.
17. Fanous AH, Van den Oord EJ, Riley BP, et al. Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia. Am 1 Psychiatry. 2005;162:1824-1832.
18. Harrison PJ, Owen MJ. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet. 2003;361:417-419.
19. Fanous AH, Kendler KS. Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework. Mol Psychiatry. 2005;10:6-13.
20. Fan JB, Zhang CS, Gu NF, et al. Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis. Biol Psychiatry. 2005;57:139-144.
21. Kwon O-B, Longart M, Vullhorst D, Hoffman DA, Buonanno A. Neuregulin-1 reverses long-term potentiation at CA1 hippocampal synapses. J Neurosci. 2005;25:9378-9383.